Spelling suggestions: "subject:"£]catenin"" "subject:"£]ßcatenin""
141 |
Targeting Cancer-Associated Fibroblasts: New Opportunity for Therapeutic Intervention in Cutaneous MelanomaYang, Kun 04 September 2018 (has links)
No description available.
|
142 |
De Novo Hair Morphogenesis in Engineered Skin SubstitutesSriwiriyanont, Penkanok 26 October 2012 (has links)
No description available.
|
143 |
Molecular Alterations in Bone Development and Bone TumorigenesisMahoney, Emilia 02 September 2009 (has links)
No description available.
|
144 |
Translational Research: Using Suramin as a PlatformShen, Tong 27 October 2010 (has links)
No description available.
|
145 |
The Role of Glycogen Synthase Kinase in Glioblastoma Multiforme Migration and InvasionWilliams, Shanté Patrice 17 March 2011 (has links)
No description available.
|
146 |
ROLE OF PSORIASIN (S100A7) IN ESTROGEN RECEPTOR POSITIVE BREAST CANCERSDeol, Yadwinder S. 27 June 2012 (has links)
No description available.
|
147 |
Single-Molecule Study of β-Catenin Translocation and the Role of Custos in its RegulationSchnell, Steven, 0000-0001-5535-9342 January 2020 (has links)
The nuclear pore complex is closely involved in the regulation and control of many cellular processes, including the movement of molecules into and out of the nucleus along with the regulation of gene transcription. It is therefore a major barrier for controlling the passage of signaling molecules into and out of the nucleus. β-catenin is one such signaling molecule, and a primary signaling molecule of the Wnt signaling pathway. How the passage of β-catenin into and out of the nucleus is controlled remains poorly defined. This signaling pathway governs major developmental processes, including cell fate determination, proliferation, motility and primary axis and head formation during development. In this study, we use super-resolution microscopy to show that β-catenin import requires Custos as a docking protein. Custos and β-catenin form a complex in the cytoplasm and move together through the NPC into the nucleus, where they dissociate in the nucleus. Further, we provide evidence that import of β-catenin into the nucleus is a regulatory event at the NPC and define regions within the β-catenin protein required for this regulation. / Biology
|
148 |
Hepatitis B x Antigen Promotes "Stemness" in the Pathogenesis of Hepatocellular CarcinomaFriedman, Tiffany Ilene January 2012 (has links)
Hepatitis B virus (HBV) is a major etiologic agent of chronic liver disease (CLD) and hepatocellular carcinoma (HCC). The virally encoded X antigen, HBx, contributes importantly to the development of HCC through its trans-activating role in various signal transduction pathways. Pathways implicated in stem cell self-renewal also contribute to carcinogenesis. Thus, experiments were designed to test if HBx triggers malignant transformation by promoting properties that are characteristic of cancer stem cells (CSCs). To test this hypothesis, HBx expressing (HepG2X) and control (HepG2CAT) human cell lines were assayed for phenotypic and molecular characteristics of "stemness." Western blotting of protein extracts from HepG2X and HepG2CAT cells as well as immunohistochemical staining of HCC and adjacent liver tissue sections from HBV infected patients showed up-regulation of "stemness"-associated (EpCAM and beta-catenin) and "stemness" (Oct-4, Nanog, Klf-4) markers by HBx. Moreover, HBx stimulated cell migration and spheroid formation. HBx expression was also associated with depressed levels of E-cadherin and subsequent activation of beta-catenin and EpCAM. Results from ChIP-chip data performed previously in this lab suggest an associative link between HBx and the expression of epigenetic co-repressor, mSin3A, which is known to repress E-cadherin when complexed with histone deacetylases. Thus, experiments were also designed to test if HBx represses the E-cadherin gene (CDH1) through histone deacetylation by the mSin3A/HDAC complex. In HepG2X cells, decreased levels of E-cadherin and elevated levels of mSin3A were detected. Reciprocal immunoprecipitation with anti-HBx and anti-mSin3A demonstrated mutual binding. Further, HBx-mSin3A co-localization was showed by immunofluorescent staining. Chromatin immunoprecipitation revealed that HBx mediated the recruitment of the mSin3A/HDAC complex to the CDH1 promoter. HDAC inhibition by Trichostatin A treatment restored E-cadherin expression. Thus, HBx-associated epigenetic repression of E-cadherin and up-regulated expression of multiple "stemness" markers support the hypothesis that HBx contributes to hepatocarcinogenesis, at least in part, by promoting changes in gene expression that are characteristic of CSCs. This work is the first to propose that HBV promotes "stemness" in the pathogenesis of HCC. / Biology
|
149 |
Bi-directional vulnerability of brain tumors to Wnt signalingManoranjan, Branavan January 2019 (has links)
Brain tumors represent a leading cause of cancer mortality, of which medulloblastoma (MB) and glioblastoma (GBM) represent the most frequent malignant pediatric and adult brain tumors, respectively. The identification of a rare clonal population of cells, termed cancer stem cells (CSCs) or brain tumor-initiating cells (BTICs), as having the ability to initiate, proliferate, and maintain tumor growth has offered a developmental framework for studying MB and GBM. Evidence in support of cell signaling programs carried forward from brain development into oncogenesis have provided opportunities for BTIC-directed therapies targeting the key BTIC property of self-renewal. Given that neural stem cells (NSCs) must maintain a relative balance between self-renewal and differentiation, brain tumorigenesis may be conceptualized as a disease of unregulated BTIC self-renewal. In this work, I aim to demonstrate the re-emergence of self-renewal genes that regulate NSCs in BTICs, use the Wnt pathway as a model by which these genes may be regulated in a context-specific manner, and identify clinically tractable therapies directed at the overall BTIC self-renewal signaling machinery. Specifically, in Chapter 2, I describe the presence of a shared signaling program between NSCs and MB BTICs consisting of Bmi1 and FoxG1. In Chapter 3, I provide evidence in support of a context-specific tumor suppressive function for activated Wnt/β-catenin signaling in MB. Lastly, in Chapter 4, I demonstrate a CD133-AKT-Wnt signaling axis in which CD133 functions as a putative cell surface receptor for AKT-dependent Wnt activation in GBM. Overall, the body of this thesis offers a mechanistic model by which BTICs may be regulated and targeted to impair tumor growth and improve overall survivorship in childhood MB and adult GBM. / Thesis / Doctor of Philosophy (PhD)
|
150 |
The β-Catenin/Yap Signaling Axis Is a Key Regulator of Melanoma-Associated FibroblastsLiu, Tianyi, Zhou, Linli, Yang, Kun, Iwasawa, Kentaro, Kadekaro, Ana Luisa, Takebe, Takanori, Andl, Thomas, Zhang, Yuhang 24 December 2019 (has links)
β-catenin is a multifunctional protein that plays crucial roles in embryonic development, physiological homeostasis, and a wide variety of human cancers. Previously, we showed that in vivo targeted ablation of β-catenin in melanoma-associated fibroblasts after melanoma formation significantly suppressed tumor growth. However, when the expression of β-catenin was ablated in melanoma-associated fibroblasts before tumor initiation, melanoma development was surprisingly accelerated. How stromal β-catenin deficiency leads to opposite biological effects in melanoma progression is not completely understood. Here, we report that β-catenin is indispensable for the activation of primary human stromal fibroblasts and the mediation of fibroblast-melanoma cell interactions. Using coimmunoprecipitation and proximity ligation assays, we identified Yes-associated protein (YAP) as an important β-catenin-interacting partner in stromal fibroblasts. YAP is highly expressed in the nuclei of cancer-associated fibroblasts (CAFs) in both human and murine melanomas. Mechanistic investigation revealed that YAP nuclear translocation is significantly modulated by Wnt/β-catenin activity in fibroblasts. Blocking Wnt/β-catenin signaling in stromal fibroblasts inhibited YAP nuclear translocation. In the absence of YAP, the ability of stromal fibroblasts to remodel the extracellular matrix (ECM) was inhibited, which is consistent with the phenotype observed in cells with β-catenin deficiency. Further studies showed that the expression of ECM proteins and enzymes required for remodeling the ECM was suppressed in stromal fibroblasts after YAP ablation. Collectively, our data provide a new paradigm in which the β-catenin-YAP signaling axis regulates the activation and tumor-promoting function of stromal fibroblasts.
|
Page generated in 0.0739 seconds